主动脉假性动脉瘤腔内修复治疗效果

目的观察腔内修复术(EVAR)治疗主动脉假性动脉瘤(AP)的效果。方法回顾接受EVAR治疗的11例AP患者,分析疗效及随访情况。结果11例AP均为单一破口,EVAR技术成功率100%;术后均无内漏、出血、重要脏器缺血等并发症,无围术期死亡。术后随访2~24个月,期间3例死亡,1例失访。2例感染性AP、1例白塞综合征合并腹主动脉假性动脉瘤患者均于术后2个月死于动脉瘤复发破裂出血;另1例白塞综合征并发腹主动脉假性动脉瘤术后1年复发,植入左髂总动脉覆膜支架后好转;其余6例覆膜支架通畅,无移位、内漏及瘤腔内血栓形成。结论EVAR治疗主动脉假性动脉瘤安全、有效,预后与病因有关。

Effect of endovascular aneurysm repair in treatment of aortic pseudoaneurysms

Objective To observe the effect of endovascular aneurysm repair (EVAR) in treatment of aortic pseudoaneurysms (AP). Methods Date of 11 AP patients treated with EVAR were retrospectively reviewed, and the treatment effect and follow-up were analyzed. Results Single breach of AP was found in all 11 patients, and the technical successful rate of EVAR was 100%. No complication such as endoleakage, bleeding, ischemia of important organs nor perioperative death occurred. The follow-up period was 2 to 24 months. During the follow-up period, 3 patients died and 1 was lost to follow-up. Two patients with infectious AP and 1 Behcet syndrome patient complicated with abdominal AP died of bleeding due to recurrent rupture of the aneurysm 2 months after operation. AP recurred 1 year after operation in 1 patient with Behcet syndrome, and another stent graft was implanted in the left common iliac artery. The stent grafts were unobstructed in the remaining 6 patients without displacement and endoleakage, and no thrombosis was found in the aneurysm. Conclusion EVAR is an effective and safe method for treatment of AP, and the prognosis is related to the etiology of AP.